查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1621372

小分子原料药市场：按类型、产品、应用分类 - 全球预测 2025-2030

Small-Molecule APIs Market by Type (Biological, Synthetic), Production (Contract Manufacturing, In-House Manufacturing), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年小分子原料药市值为1843.2亿美元，预计2024年将达到1973.5亿美元，复合年增长率为7.26%，到2030年将达到3011.9亿美元。

小分子原料药市场范围包括对药物製剂至关重要的多种药物成分。这些分子是小的有机化合物，有助于诊断、治疗和预防疾病。由于慢性病的增加、医疗基础设施的扩大和世界人口的老化，对有效药物的需求增加，对小分子原料药的需求随之而来。其用途广泛，包括癌症、循环系统疾病、中枢神经系统疾病及感染疾病。最终用途范围主要包括製药和生物技术公司以及受託製造厂商(CMO)。市场成长很大程度上受到学名药快速成长、重磅药物专利到期以及药物发现技术进步的影响。研发活动的活性化和有利的法律规范提供了更多潜在的商机。公司可以透过专注于个人化医疗和扩大其生物相似药产品组合来利用这些机会。然而，挑战包括严格的监管合规性、高投资成本和复杂的製造流程。众多努力创新并赢得市场占有率的参与者的出现也加剧了竞争格局。提供成长潜力的创新和研究领域包括连续製造流程、环保合成路线和先进的药物传输系统。此外，人工智慧和机器学习在药物设计和开发中的集成为业务扩展提供了新的途径。关于市场性质的竞争考察强调了由技术进步和不断变化的监管政策驱动的市场的动态和竞争性质。企业应优先考虑策略联盟和持续创新以获得优势。透过解决关键挑战并专注于永续实践，公司可以成功驾驭市场并实现成长。

主要市场统计
基准年[2023] 1843.2亿美元
预计年份 [2024] 1973.5亿美元
预测年份 [2030] 3011.9亿美元
复合年增长率（%） 7.26%

市场动态：快速发展的小分子原料药市场的关键市场洞察

小分子原料药市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 随着世界老年人口的增加，慢性病的流行
    • 全球对学名药的需求不断增长
  • 市场限制因素
    • 小分子原料药相关的高成本
  • 市场机会
    • 药物发现和开发的持续进步
    • 与生物製药公司合作进行联合治疗
  • 市场挑战
    • 药物研发严格的监管要求

波特五力：开拓小分子原料药市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解小分子原料药市场的外部影响

外部宏观环境因素在塑造小分子原料药市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解小分子原料药市场的竞争状况

小分子原料药市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵小分子原料药市场供应商绩效评估

FPNV定位矩阵是评估小分子原料药市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议 规划小分子原料药市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，小分子原料药市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球慢性病增加和人口老化
      • 全球对学名药的需求增加
    • 抑制因素
      • 小分子原料药相关的高成本
    • 机会
      • 药物发现和开发的持续进步
      • 与生物製药公司合作进行联合治疗
    • 任务
      • 药物研发严格的监管要求
  • 市场区隔分析
    • 类型：由于副作用较少，越来越多使用基于生物的小分子原料药
    • 生产：增加内部製造以确保品质标准
    • 应用：肿瘤学的不断进步将提高小分子原料药的利用率。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章小分子原料药市场：依类型

  • 生物
  • 合成

第七章 小分子原料药市场创造者

  • 契约製造
  • 内部製造

第八章小分子原料药市场：依应用分类

  • 心血管
  • 糖尿病
  • 免疫疾病
  • 肿瘤学

第九章北美及南美小分子原料药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太小分子原料药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲小分子原料药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Lonza 推出人工智慧服务以简化候选药物的路线探索
    • 无锡 STA 扩大 API反应器产能并将胜肽生产能力增加两倍以满足全球需求
    • Granules 投资 2.5 亿美元新建绿色小分子 API 生产设施
    • SST Corporation与Viwit Pharmaceuticals建立策略联盟
    • API 与滑铁卢大学科学家合作开发针对冠状病毒的广谱小分子疗法
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Agilent Technologies, Inc.
  • Alacrita Holdings Limited
  • Albemarle Corporation
  • Aspen Group
  • Astrazeneca PLC
  • Aurobindo Pharma Limited
  • Bachem Holding AG
  • Bio-Rad Laboratories, Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb
  • Cambrex Corporation by Permira funds
  • Carlyle Group
  • Charles River Laboratories International, Inc.
  • Deciphera Pharmaceuticals, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd,
  • Gilead Sciences, Inc
  • GlaxoSmithKline PLC
  • Koninklijke DSM NV
  • Lonza Group AG
  • Merck KGaA
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-43539E5D3217

The Small-Molecule APIs Market was valued at USD 184.32 billion in 2023, expected to reach USD 197.35 billion in 2024, and is projected to grow at a CAGR of 7.26%, to USD 301.19 billion by 2030.

The scope of the Small-Molecule APIs market encompasses a wide range of pharmaceutical ingredients that are crucial for drug formulation. These molecules are small organic compounds that aid in the diagnosis, treatment, and prevention of diseases. The necessity for small-molecule APIs is driven by the increasing demand for effective medications due to rising chronic diseases, expanding healthcare infrastructure, and an aging global population. Their applications are vast, including oncology, cardiovascular, central nervous system disorders, and infectious diseases, among others. The end-use scope primarily covers pharmaceutical and biotechnology companies, as well as contract manufacturing organizations (CMOs). Market growth is influenced significantly by the surge in generic drug production, patent expirations of blockbuster drugs, and advancements in drug discovery technologies. Increased research and development activities and favorable regulatory frameworks further provide potential opportunities. Companies can capitalize on these opportunities by focusing on personalized medicine and expanding their biosimilars portfolio. However, limitations such as stringent regulatory compliance, high investment costs, and complex manufacturing processes present challenges. The competitive landscape is also intensified by the presence of numerous players striving for innovation and market share. Areas of innovation and research that offer growth potential include continuous manufacturing processes, eco-friendly synthesis routes, and advanced drug delivery systems. Additionally, integration of AI and machine learning in drug design and development presents new avenues for business expansion. Insights into the nature of the market highlight its dynamic and competitive nature, driven by technological advancements and evolving regulatory policies. Companies should prioritize strategic collaborations and continuous innovation to stay ahead. By addressing key challenges and focusing on sustainable practices, businesses can successfully navigate the market and achieve growth.

KEY MARKET STATISTICS
Base Year [2023] USD 184.32 billion
Estimated Year [2024] USD 197.35 billion
Forecast Year [2030] USD 301.19 billion
CAGR (%) 7.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Small-Molecule APIs Market

The Small-Molecule APIs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic diseases coupled with increasing geriatric population globally
    • Rising demand for generic drugs worldwide
  • Market Restraints
    • High cost associated with small-molecule APIs
  • Market Opportunities
    • Ongoing advancements in drug discovery and development
    • Collaborations with bio-pharmaceutical companies for combination therapies
  • Market Challenges
    • Stringent regulatory requirements for drug development

Porter's Five Forces: A Strategic Tool for Navigating the Small-Molecule APIs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Small-Molecule APIs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Small-Molecule APIs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Small-Molecule APIs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Small-Molecule APIs Market

A detailed market share analysis in the Small-Molecule APIs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Small-Molecule APIs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Small-Molecule APIs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Small-Molecule APIs Market

A strategic analysis of the Small-Molecule APIs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Small-Molecule APIs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Agilent Technologies, Inc., Alacrita Holdings Limited, Albemarle Corporation, Aspen Group, Astrazeneca PLC, Aurobindo Pharma Limited, Bachem Holding AG, Bio-Rad Laboratories, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Cambrex Corporation by Permira funds, Carlyle Group, Charles River Laboratories International, Inc., Deciphera Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd,, Gilead Sciences, Inc, GlaxoSmithKline PLC, Koninklijke DSM N.V., Lonza Group AG, Merck KGaA, Pfizer, Inc., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Small-Molecule APIs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Biological and Synthetic.
  • Based on Production, market is studied across Contract Manufacturing and In-House Manufacturing.
  • Based on Application, market is studied across Cardiovascular, Diabetes, Immunological Disorders, and Oncology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic diseases coupled with increasing geriatric population globally
      • 5.1.1.2. Rising demand for generic drugs worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with small-molecule APIs
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in drug discovery and development
      • 5.1.3.2. Collaborations with bio-pharmaceutical companies for combination therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for drug development
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing inclination towards biological based small-molecule APIs due to its reduced side effects
    • 5.2.2. Production: Increasing in-house small-molecule APIs manufacturing to ensure quality standards
    • 5.2.3. Application: Ongoing advancements in oncology enhances the utilization of small-molecule APIs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Small-Molecule APIs Market, by Type

  • 6.1. Introduction
  • 6.2. Biological
  • 6.3. Synthetic

7. Small-Molecule APIs Market, by Production

  • 7.1. Introduction
  • 7.2. Contract Manufacturing
  • 7.3. In-House Manufacturing

8. Small-Molecule APIs Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular
  • 8.3. Diabetes
  • 8.4. Immunological Disorders
  • 8.5. Oncology

9. Americas Small-Molecule APIs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Small-Molecule APIs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Small-Molecule APIs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Lonza Launches AI-Powered Service to Simplify Route Scouting for New Drug Candidates
    • 12.3.2. WuXi STA Expands API Reactor Volume and Triples Peptide Manufacturing Capacity to Meet Global Demand
    • 12.3.3. Granules Investing USD 250 Million for New Green Small-Molecule API Mfg Facility
    • 12.3.4. SST Corporation and Viwit Pharmaceuticals Establish Strategic Collaboration
    • 12.3.5. API partners with the University of Waterloo scientists to develop broad-spectrum small molecule therapeutics against coronaviruses
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Alacrita Holdings Limited
  • 4. Albemarle Corporation
  • 5. Aspen Group
  • 6. Astrazeneca PLC
  • 7. Aurobindo Pharma Limited
  • 8. Bachem Holding AG
  • 9. Bio-Rad Laboratories, Inc.
  • 10. Boehringer Ingelheim GmbH
  • 11. Bristol-Myers Squibb
  • 12. Cambrex Corporation by Permira funds
  • 13. Carlyle Group
  • 14. Charles River Laboratories International, Inc.
  • 15. Deciphera Pharmaceuticals, Inc.
  • 16. Dr. Reddy's Laboratories Ltd.
  • 17. F. Hoffmann-La Roche Ltd,
  • 18. Gilead Sciences, Inc
  • 19. GlaxoSmithKline PLC
  • 20. Koninklijke DSM N.V.
  • 21. Lonza Group AG
  • 22. Merck KGaA
  • 23. Pfizer, Inc.
  • 24. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. SMALL-MOLECULE APIS MARKET RESEARCH PROCESS
  • FIGURE 2. SMALL-MOLECULE APIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMALL-MOLECULE APIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SMALL-MOLECULE APIS MARKET DYNAMICS
  • TABLE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023